Madrigal Pharmaceuticals, Inc.
2018 Q3 - 2025 Q4 (30 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 5,961 | 0.0% | 10,237 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 4,957 | 0.0% | 10,807 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 3,045 | 0.0% | 10,062 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 3,462 | 0.0% | 10,453 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 3,338 | 0.0% | 10,818 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 2,148 | 0.0% | 10,123 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 2,836 | 0.0% | 10,123 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 2,026 | 0.0% | 7,586 | 3/31/2024 |
| 2023 Q4 | 4/22/2024 | 1,795 | 0.0% | 7,758 | 12/31/2023 |
| 2023 Q3 | 5/9/2024 | 1,048 | 0.0% | 7,177 | 9/30/2023 |
| 2023 Q2 | 4/29/2024 | 1,658 | 0.0% | 7,177 | 6/30/2023 |
| 2023 Q1 | 5/9/2024 | 1,619 | 0.0% | 6,682 | 3/31/2023 |
| 2022 Q4 | 5/10/2024 | 1,939 | 0.0% | 6,682 | 12/31/2022 |
| 2022 Q3 | 5/10/2024 | 434 | 0.0% | 6,682 | 9/30/2022 |
| 2022 Q2 | 5/10/2024 | 478 | 0.0% | 6,682 | 6/30/2022 |
| 2022 Q1 | 5/10/2024 | 656 | 0.0% | 6,682 | 3/31/2022 |
| 2021 Q4 | 5/17/2024 | 357 | 0.0% | 4,214 | 12/31/2021 |
| 2021 Q3 | 5/17/2024 | 294 | 0.0% | 3,687 | 9/30/2021 |
| 2021 Q2 | 5/17/2024 | 359 | 0.0% | 3,687 | 6/30/2021 |
| 2021 Q1 | 5/17/2024 | 431 | 0.0% | 3,687 | 3/31/2021 |
| 2020 Q4 | 5/24/2024 | 410 | 0.0% | 3,687 | 12/31/2020 |
| 2020 Q3 | 5/24/2024 | 438 | 0.0% | 3,687 | 9/30/2020 |
| 2020 Q2 | 5/24/2024 | 418 | 0.0% | 3,687 | 6/30/2020 |
| 2020 Q1 | 7/12/2023 | 246 | 0.0% | 3,687 | 3/31/2020 |
| 2019 Q4 | 7/12/2023 | 336 | 0.0% | 3,687 | 12/31/2019 |
| 2019 Q3 | 7/12/2023 | 318 | 0.0% | 3,687 | 9/30/2019 |
| 2019 Q2 | 7/12/2023 | 386 | 0.0% | 3,687 | 6/30/2019 |
| 2019 Q1 | 7/13/2023 | 391 | 0.0% | 3,123 | 3/31/2019 |
| 2018 Q4 | 7/13/2023 | 352 | 0.0% | 3,123 | 12/31/2018 |
| 2018 Q3 | 7/13/2023 | 669 | 0.0% | 3,123 | 9/30/2018 |